SwingTrade Member Forum

[chapter54]

aria

if not already mentioned, ya'll may want to watch ARIA
tomorrow. could gap and fall back, or just keep going.....

INDIANAPOLIS (AP) -- A federal jury ruled Thursday in favor of Ariad Pharmaceuticals Inc. in its patent-infringement lawsuit targeting Eli Lilly and Co.'s top-selling osteoporosis drug and a separate sepsis medication.

The U.S. District Court jury in Boston awarded Ariad and three co-plaintiffs, including the Massachusetts Institute of Technology, about $65.2 million. The award includes a 2.3 percent royalty on future U.S. sales of Evista and Xigris until the patent expires in 2019. Last year, the two drugs had combined worldwide sales of about $1.3 billion for the Indianapolis-based company.

http://biz.yahoo.com/ap/060504/lilly_patent.html?.v=8

regards.....

~ ric